ADIL
NASDAQ · Pharmaceuticals
Adial Pharmaceuticals Inc
$3.81
-1.07 (-21.93%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+361.2% upside
Low Target
$13.09
Average Target
$17.57
High Target
$22.70
Current Price
$3.81
Current
$3.81
$3.81
Target
$17.57
$17.57
$13.09
$17.57 avg
$22.70
Scenario Analysis
Bear Case
$13.09
243.6%
Low target
Base Case
$17.57
+361.2%
Avg target
Bull Case
$22.70
+495.8%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$8.75
-56.5% from high
52-Week Low
$1.31
+190.8% from low
Target vs 52W High
$17.57
+100.8% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.68
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals